Research & Analysis
ACP-105: What the Research Actually Shows About This Experimental SARM
ACP-105 is an experimental, non-FDA-approved nonsteroidal selective androgen receptor modulator studied so far only in animal and equine-metabolism research, with no published human clinical trial data on its safety or effectiveness.
SARMS Institute Research Desk. Compiled from primary sources. Last updated 20 July 2026.
This page is for education and does not provide medical or legal advice. No SARM is approved for human use.
This page is for education and does not provide medical or legal advice. No SARM is approved for human use.